Law enforcement agencies from across Southern Oregon gathered Monday to honor Jackson County Sheriff’s Corrections Deputy Kenneth “KC” Merck, who died unexpectedly on June 17, 2025, following a sudden ...

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients taking Keytruda can reduce ...

Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance ...

U.S. biopharmaceutical giant Merck announced the start of construction for a $1-billion, 470,000-sq-ft biologics center of excellence in Wilmington, Del. Officially called Merck Wilmington Biotech ...

Merck said last week its biggest tariff exposure is through Keytruda and it has enough US inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.

Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that could eventually provide thousands of jobs.

Merck (NYSE:MRK) recently announced promising results from its Phase 3 KEYNOTE-689 trial of KEYTRUDA, presented at the AACR Annual Meeting, which seems likely to have bolstered investor confidence ...

Pharmaceutical giant Merck will close its plant in Northumberland County, Pennsylvania. According to a WARN Notice filed with the state's Department of Labor and Industry, three rounds of layoffs ...

This positions MERK among the best new crypto projects, providing real-world utility beyond traditional memecoin speculation. Future roadmap: Expanding the AI-Powered meme economy ...

Keytruda will generate $25 billion in sales for Merck this year. But its patent is about to expire, leaving Merck with a gaping hole to fill—and a stock price that could be at risk.

AI helps Merck more quickly generate a first draft, speeding up the journey to the final document submitted to regulators, Studney said. But he emphasized that AI is not replacing humans.